 |
|
Clinical Trial RegistrationLooking Back and Moving Ahead
Christine Laine, MD, MPH;
Richard Horton, FMedSci;
Catherine D. DeAngelis, MD, MPH;
Jeffrey M. Drazen, MD;
Frank A. Frizelle, MBChB, MMedSci;
Fiona Godlee, MBBChir, BSc;
Charlotte Haug, MD, PhD, MSc;
Paul C. Hébert, MD, MHSc;
Sheldon Kotzin, MLS;
Ana Marusic, MD, PhD;
Peush Sahni, MS, PhD;
Torben V. Schroeder, MD, DMSc;
Harold C. Sox, MD;
Martin B. Van Der Weyden, MD;
Freek W.A. Verheugt, MD
JAMA. 2007;298:93-94. Published online June 4, 2007 (doi:10.1001/jama.298.1.jed70037).
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In 2005, the International Committee of Medical Journal Editors (ICMJE) initiated a policy requiring investigators to deposit information about trial design into an accepted clinical trials registry before the onset of patient enrollment.1 This policy aimed to ensure that information about the existence and design of clinically directive trials was publicly available, an ideal that leaders in evidence-based medicine have advocated for decades.2 The policy precipitated much angst among research investigators and sponsors, who feared that registration would be burdensome and would stifle competition. Yet, . . . [Full Text of this Article]
Author Affiliations: Dr Laine is senior deputy editor, Annals of Internal Medicine; Dr Horton is editor, The Lancet; Dr DeAngelis is editor-in-chief, JAMA; Dr Drazen is editor-in-chief, New England Journal of Medicine; Dr Frizelle is editor-in-chief, The New Zealand Medical Journal; Dr Godlee is editor-in-chief, BMJ; Dr Haug is editor-in-chief, Norwegian Medical Journal; Dr Hébert is editor-in-chief, CMAJ; Mr Kotzin is executive editor, MEDLINE, National Library of Medicine; Dr Marusic is editor, Croatian Medical Journal; Dr Sahni is representative and past president, World Association of Medical Editors; Dr Schroeder is editor, Journal of the Danish Medical Association; Dr Sox is editor, Annals of Internal Medicine; Dr Van Der Weyden is editor, The Medical Journal of Australia; and Dr Verheugt is executive editor, Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Comment on alemtuzumab and inclusion body myositis
Greenberg
Brain 2009;0:awp275v1-awp275.
FULL TEXT
Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
Mathieu et al.
JAMA 2009;302:977-984.
ABSTRACT
| FULL TEXT
Better regulation of industry-sponsored clinical trials is long overdue.
Wynia and Boren
J Law Med Ethics 2009;37:410-419.
Bidirectional Conflicts of Interest Involving Industry and Medical Journals: Who Will Champion Integrity?
Lanier
Mayo Clin Proc. 2009;84:771-775.
FULL TEXT
How do disclosure policies fail? Let us count the ways
de Melo-Martin and Intemann
FASEB J. 2009;23:1638-1642.
ABSTRACT
| FULL TEXT
Publication of Clinical Trials
Swiontkowski
JBJS 2009;91:1-2.
FULL TEXT
The Primary Care Research Object Model (PCROM): A Computable Information Model for Practice-based Primary Care Research
Speedie et al.
J. Am. Med. Inform. Assoc. 2008;15:661-670.
ABSTRACT
| FULL TEXT
Patient-Important Outcomes in Registered Diabetes Trials
Gandhi et al.
JAMA 2008;299:2543-2549.
ABSTRACT
| FULL TEXT
Critical Lessons From the ENHANCE Trial
Greenland and Lloyd-Jones
JAMA 2008;299:953-955.
FULL TEXT
Publication of Clinical Trials in JAMA: Information for Authors
Fontanarosa and DeAngelis
JAMA 2008;299:95-96.
FULL TEXT
Mayo Clinic Proceedings 2008: Content Refinement, Continuing Medical Education Credit, Web Site Improvements, and More
Lanier
Mayo Clin Proc. 2008;83:13-16.
FULL TEXT
Institutional Review Boards Should Require Clinical Trial Registration
Levin and Palmer
Arch Intern Med 2007;167:1576-1580.
FULL TEXT
|
